BRIEF published on 06/11/2024 at 09:05, 4 months 27 days ago Medincell rejoint l'indice Euronext Tech Leaders Innovation Secteur Technologique Visibilité Des Investisseurs Médine Leaders Technologiques D'Euronext
BRIEF published on 06/11/2024 at 09:05, 4 months 27 days ago Medincell Joins Euronext Tech Leaders Index Innovation Tech Sector Investor Visibility Medincell Euronext Tech Leaders
PRESS RELEASE published on 06/11/2024 at 09:00, 4 months 27 days ago Informations privilégiées / Autres communiqués Medincell rejoint l’indice Euronext Tech Leaders, accédant à un vaste écosystème et renforçant sa visibilité auprès d'investisseurs internationaux. La technologie BEPO® innovante de Medincell est reconnue Croissance Innovation Medincell Euronext Tech Leaders BEPO®
PRESS RELEASE published on 06/11/2024 at 09:00, 4 months 27 days ago Inside Information / Other news releases Medincell joins Euronext Tech Leaders, gaining access to a broad investor base and support services. CEO Christophe Douat highlights the company's growth and tech innovation leadership Tech Sector Financial Strategy Investor Base Medincell Euronext Tech Leaders
BRIEF published on 05/10/2024 at 18:05, 5 months 28 days ago Medincell annonce les détails sur le capital et les droits de vote conformément à la réglementation Euronext Paris Droits De Vote Réglementation Financière Capital Social Medincell
BRIEF published on 05/10/2024 at 18:05, 5 months 28 days ago Medincell announces details on capital and voting rights in accordance with regulations Euronext Paris Share Capital Voting Rights Financial Regulation Medincell
PRESS RELEASE published on 05/10/2024 at 18:00, 5 months 28 days ago Informations privilégiées / Autres communiqués Annonce mensuelle des actions et droits de vote de Medincell sur Euronext Paris. Medincell développe des médicaments injectables à action prolongée pour divers domaines thérapeutiques Euronext Paris AMF Biopharmaceutique Medincell Médicaments Injectables
BRIEF published on 05/08/2024 at 12:35, 5 months 30 days ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
BRIEF published on 05/08/2024 at 12:35, 5 months 30 days ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
PRESS RELEASE published on 05/08/2024 at 12:30, 5 months 30 days ago Inside Information / Other news releases Teva and Medincell announce positive Phase 3 efficacy results from SOLARIS trial evaluating TEV-'749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia Schizophrenia Medincell Teva Phase 3 Efficacy Results SOLARIS Trial
Published on 11/08/2024 at 10:00, 1 hour 55 minutes ago BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 2 hours 55 minutes ago Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards
Published on 11/08/2024 at 07:00, 4 hours 55 minutes ago Polaris Renewable Energy Announces Fixed Income Meetings
Published on 11/08/2024 at 03:00, 8 hours 55 minutes ago Alset AI Appoints Wall Street Veteran and Venture Executive as President
Published on 11/08/2024 at 01:25, 10 hours 30 minutes ago PetroFrontier Corp. Announces Execution of Definitive Agreements for $15.1 Million Funding Arrangement
Published on 11/08/2024 at 11:30, 25 minutes ago Shelly Group: Invitation to unaudited 9M 2024 earnings webcast/call on 14 November 2024
Published on 11/08/2024 at 11:12, 43 minutes ago Original-Research: Masterflex SE (von Montega AG): Kaufen
Published on 11/08/2024 at 11:10, 44 minutes ago Ossiam ESG Shiller Barclays CAPE® Global Sector UCITS ETF: notice of closure
Published on 11/08/2024 at 11:06, 49 minutes ago Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
Published on 11/08/2024 at 11:00, 55 minutes ago BluSky Carbon CEO Presents a Case for ClimateTech Optimism
Published on 11/08/2024 at 08:00, 3 hours 55 minutes ago DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Published on 11/07/2024 at 19:00, 16 hours 55 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/07/2024 at 19:00, 16 hours 55 minutes ago ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 16 hours 55 minutes ago ALTAREIT : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 16 hours 55 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
